CDKN2B-AS1 and osteosarcoma: Regarding the effects of ncRNAs on cisplatin, it was discovered that a knockdown of lncRNA ANRIL enhances osteosarcoma cells’ sensitivity to cisplatin-induced cytotoxicity.